Evidence map›Paper›PMID 37109410›Full record

ArticleLife (Basel, Switzerland)2023

Agata Ocenasova, Ivana Shawkatova, Juraj Javor, Zuzana Parnicka, Gabriel Minarik, Maria Kralova, Iliana Kiralyova, Iveta Mikolaskova, Vladimira Durmanova

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. A Specific Haplotype of theDiagnostics (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Agata OcenasovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
Ivana ShawkatovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0002-7803-5815
Juraj JavorInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0002-7741-5779
Zuzana ParnickaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
Gabriel MinarikMedirex Group Academy, Ltd., 820 16 Bratislava, Slovakia.
Maria KralovaClinic of Psychiatry, Faculty of Medicine, University Hospital, Comenius University in Bratislava, 813 69 Bratislava, Slovakia.
Iliana KiralyovaCare Centre Centrum Memory, 851 03 Bratislava, Slovakia.
Iveta MikolaskovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
Vladimira DurmanovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
Comenius University Bratislava · SKMedirex Group Academy · SK

Funding

Scientific Grant Agency of Ministry of Education, Science, Research and Sport of Slovak Republic and Slovak Academy of Sciences VEGA grant No. 1/0738/20
6 · The paper itself

Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterised by progressive loss of memory. In the AD brain, matrix metalloproteinases (MMPs) are involved in the disruption of the blood-brain barrier resulting in a neuroinflammatory response. The objective of our investigation was to assess the association of

Indexed as

Alzheimer’s diseasegenotypingmatrix metalloproteinase 2polymorphism

Identifiers

PMID37109410
PMCPMC10143987
OpenAlexW4361003961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.